Xuan Huang

Dr. Xuan Huang

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2023 in Oncology Letters
Verified
Journal Article
Open access
PDF file
LZLei Zhou
Lei Zhou
QZQi Zhang
Qi Zhang
QZQing Zhu
Qing Zhu
YZYuan Zhan
Yuan Zhan
YLYong Li
Yong Li
XHXuan Huang
Xuan Huang
The Warburg effect indicates that cancer cells survive through glycolysis under aerobic conditions; as such, the topic of cancer metabolism has aroused interest. It is requisite to further explore cancer metabolism, as it helps to simultaneously explain the process of carcinogenesis and guide therapy. The flexible metabolism of cancer cells, which is the result of metabolic reprogramming, can meet the basic needs of cells, even in a nutrition‑deficient environment. Glutamine is the most abundant non‑essential amino acid in the circulation, and along with glucose, comprise the two basic nutrients of cancer cell metabolism. Glutamine is crucial in non‑small cell lung cancer (NSCLC) cells and serves an important role in supporting cell growth, activating signal transduction and maintaining redox homeostasis. In this perspective, the present review aims to provide a new therapeutic strategy of NSCLC through inhibiting the metabolism of glutamine. This review not only summarizes the significance of glutamine metabolism in NSCLC cells, but also enumerates traditional glutamine inhibitors along with new targets. It also puts forward the concept of combination therapy and patient stratification with the aim of comprehensively showing the effect and prospect of targeted glutamine metabolism in NSCLC therapy. This review was completed by searching for keywords including ‘glutamine’, ‘NSCLC’ and ‘therapy’ on PubMed, and screening out articles.

22 May 2024 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
QZQi Zhang
Qi Zhang
YLYong Li
Yong Li
QZQing Zhu
Qing Zhu
TXTao Xie
Tao Xie
YXYue Xiao
Yue Xiao
XHXuan Huang
Xuan Huang
As a typical E3 ligase, TRIM65 (tripartite motif containing 65) is involved in the regulation of antiviral innate immunity and the pathogenesis of certain tumors. However, the role of TRIM65 in renal cell carcinoma (RCC) and the underlying mechanism has not been determined yet. In this study, we identified TRIM65 as a novel oncogene in RCC, which enhanced the tumor cell proliferation and anchorage-independent growth abilities both in vitro and in vivo. Moreover, we found that TRIM65-regulated RCC proliferation mainly via direct interaction with BTG3 (BTG anti-proliferation factor 3), which in turn induced the K48-linked ubiquitination and subsequent degradation through K41 amino acid. Furthermore, TRIM65 relieved G2/M phase cell cycle arrest via degradation of BTG3 and regulated downstream factors. Further studies revealed that TRIM65 acts through TRIM65-BTG3-CyclinD1 axis and clinical sample IHC chip data indicated a negative correction between TRIM65 and BTG3. Taken together, our findings demonstrated that TRIM65 promotes RCC cell proliferation via regulation of the cell cycle through degradation of BTG3, suggesting that TRIM65 may be a promising target for RCC therapy.

11 January 2024 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
YHYingjie Huang
Yingjie Huang
TCTao Chen
Tao Chen
MJMing Jiang
Ming Jiang
CXChenlu Xiong
Chenlu Xiong
CMChao Mei
Chao Mei
YLYong Li
Yong Li
Intestinal ischemia-reperfusion (II/R) injury is an urgent clinical disease with high incidence and mortality, and impaired intestinal barrier function caused by excessive apoptosis of intestinal cells is an important cause of its serious consequences. Tripartite motif-containing protein 65 (TRIM65) is an E3 ubiquitin ligase that is recently reported to suppress the inflammatory response and apoptosis. However, the biological function and regulation of TRIM65 in II/R injury are totally unknown. We found that TRIM65 was significantly decreased in hypoxia-reoxygenation (H/R) induced intestinal epithelial cells and II/R-induced intestine tissue.TRIM65knockout mice markedly aggravated intestinal apoptosis and II/R injury. To explore the molecular mechanism of TRIM65 in exacerbating II/R-induced intestinal apoptosis and damage, thymocyte selection-associated high mobility group box factor 4 (TOX4) was screened out as a novel substrate of TRIM65 using the yeast two-hybrid system. TRIM65 binds directly to the N-terminal of TOX4 through its coiled-coil and SPRY structural domains. Immunofluorescence confocal microscopy showed that they can co-localize both in the cytoplasm and nucleus. Furthermore, TRIM65 mediated the K48 ubiquitination and degradation of TOX4 depending on its E3 ubiquitin ligase activity. In addition, TRIM65 inhibits H/R-induced intestinal epithelial apoptosis via TOX4. In summary, our results indicated that TRIM65 promotes ubiquitination and degradation of TOX4 to inhibit apoptosis in II/R. These findings provide a promising target for the clinical treatment of II/R injury.

29 June 2024 in Cell Death & Differentiation
Verified
Journal Article
Closed access
PDF file
SWSisi Wei
Sisi Wei
XHXuan Huang
Xuan Huang
QZQing Zhu
Qing Zhu
TCTao Chen
Tao Chen
YZYan Zhang
Yan Zhang
YLYong Li
Yong Li

19 June 2023 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
CXChenlu Xiong
Chenlu Xiong
XHXuan Huang
Xuan Huang
SCShibiao Chen
Shibiao Chen
YLYong Li
Yong Li
Acute lung injury (ALI) is a life-threatening pathological disease characterized by the damage of pulmonary endothelial cells and epithelial cell barriers by uncontrolled inflammation. During sepsis-induced ALI, multiple cells cooperate and communicate with each other to respond to the stimulation of inflammatory factors. However, the underlying mechanisms of action have not been fully identified, and the modes of communication therein are also being investigated. Extracellular vesicles (EVs) are a heterogeneous population of spherical membrane structures released by almost all types of cells, containing various cellular components. EVs are primary transport vehicles for microRNAs (miRNAs), which play essential roles in physiological and pathological processes in ALI. EV miRNAs from different sources participated in regulating the biological function of pulmonary epithelial cells, endothelial cells, and phagocytes by transferring miRNA through EVs during ALI induced by sepsis, which has great potential diagnostic and therapeutic values. This study aims to summarize the role and mechanism of extracellular vesicle miRNAs from different cells in the regulation of sepsis-induced ALI. It provides ideas for further exploring the role of extracellular miRNA secreted by different cells in the ALI induced by sepsis, to make up for the deficiency of current understanding, and to explore the more optimal scheme for diagnosis and treatment of ALI.

9 May 2016 in IUBMB Life
Verified
Journal Article
Open access
PDF file
YXYuan Xiang
Yuan Xiang
DLDa‐Lin Lu
Da‐Lin Lu
JLjiapeng li
jiapeng li
CYCheng‐Xi Yu
Cheng‐Xi Yu
DZDe‐Liang Zheng
De‐Liang Zheng
TZTongcun Zhang
Tongcun Zhang
Myocardin is frequently repressed during human malignant transformation, and restoration of myocardin expression in sarcoma cells contributes to the inhibition of malignant growth. However, its role in breast carcinoma has barely been addressed. Here, we reported that myocardin could inhibit the proliferation of MCF‐7 cells. Notably, we show that myocardin inhibited ERα‐mediated proliferation of breast cancer MCF‐7 via impairing ER‐dependent transcriptional activation, mainly through the inhibition of the activity of ERα. Importantly, the molecular mechanism for the inhibition of the ERα‐mediated proliferation is that myocardin inhibited the transcription and expression of ERα‐induced PCNA, Ki‐67, and E2F1 to impair ERα‐mediated proliferation of breast cancer MCF‐7. Interestingly, myocardin significantly enhanced the transcription and expression of miR‐885 depending on the CArG box in miR‐885 promoter, and miR‐885 targeted the 3′ untranslated regions (UTR) of E2F1 to silence the expression of E2F1. Thus, our data provided important and novel insights into how myocardin may deeply influence ERα‐mediated breast cancer proliferation. In conclusion, myocardin could be seen as a breast cancer tumor suppressor so that it will provide new ideas for the treatment of breast cancer. © 2016 IUBMB Life, 68(6):477–487, 2016